<DOC>
	<DOCNO>NCT02028702</DOCNO>
	<brief_summary>To investigate report health benefit ( lipid profile , inflammatory factor , cardiovascular status bone density ) novel , phytoestrogen rich , Red Clover treatment woman suffer menopause relate primary ( hot flush , night sweat , sleep disturbance weight gain ) secondary ( osteoporosis , cardiovascular change lipid metabolism ) symptom .</brief_summary>
	<brief_title>Alternative Treatments Menopausal Women</brief_title>
	<detailed_description>Menopausal symptom common phenomenon cause discomfort many middle age woman throughout world . The core symptom experience hot flush ( HF ) , night sweat , vaginal dryness sleep disturbance . Other secondary symptom sexual dysfunction , depression , anxiety , memory loss , fatigue , headache , joint pain weight gain . Moreover increase risk complication osteoporosis , cardiovascular negative change lipid profile associate reduction oestrogen post menopause . Trifolium Pratense Red Clover ( RC ) arise popular source woman experience HF contains variety phytoestrogen 's , namely isoflavones , lignans coumestans . Phytoestrogens show positive effect menopausal disorder breast cancer , cardiovascular risk factor , osteoporosis show exert non-hormonal antioxidant effect . Additionally isoflavones appear reduce bone resorbtion , help maintain bone mineral density improve lipid profile ( reduce LDL : HDL , lipoprotein A , total cholesterol may also reduce triglyceride ) . RC particularly high estrogenic isoflavones biochanin A , formononetin less degree genestein diadzein , although two former precursor genestein diadzein . Asian population high intake soy ( rich genestein diadzein ) long show low report incidence symptom menopause . The study carry 3-month parallel randomize control intervention study , consist 61 menopausal woman . During summer 2012 , 61 participant randomise 2 group ( ~30-31 group ) . The two group follow : 1 . Menopausal woman receive RC treatment - 150ml/d Red Clover ( 80mg/d isoflavones aglycone ) 2 . Menopausal woman receive placebo - 150ml placebo</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<criteria>Women age 4065 year Experiencing daily hot flush Body Mass Index ( BMI ) 2040 Irregular menstrual bleeding FSH level normal range Simultaneous participation clinical trial within last 3 month Severe cardiovascular , psychiatric , neurological , and/or kidney disease . Alcohol drug abuse acute illness . Blood pressure &gt; 160/110 Pregnant lactate woman</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>red clover</keyword>
	<keyword>menopause</keyword>
	<keyword>bioactive compound</keyword>
	<keyword>isoflavones</keyword>
	<keyword>phytoestrogen</keyword>
</DOC>